Farine H[au] - Search Results

Year	Number of Results
2011	1
2015	1
2016	1
2017	1
2018	1
2019	2
2020	2
2021	1
2022	2
2023	1

1

Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.

Welford RWD, Farine H, Steiner M, Garzotti M, Dobrenis K, Sievers C, Strasser DS, Amraoui Y, Groenen PMA, Giugliani R, Mengel E. Welford RWD, et al. Among authors: farine h. Mol Genet Metab Rep. 2022 Feb 1;30:100843. doi: 10.1016/j.ymgmr.2022.100843. eCollection 2022 Mar. Mol Genet Metab Rep. 2022. PMID: 35242574 Free PMC article.

2

Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma.

Agache I, Strasser DS, Pierlot GM, Farine H, Izuhara K, Akdis CA. Agache I, et al. Among authors: farine h. J Allergy Clin Immunol. 2018 Jan;141(1):442-445. doi: 10.1016/j.jaci.2017.08.027. Epub 2017 Oct 5. J Allergy Clin Immunol. 2018. PMID: 28987809 No abstract available.

3

Impact of high-altitude therapy on type-2 immune responses in asthma patients.

Boonpiyathad T, Capova G, Duchna HW, Croxford AL, Farine H, Dreher A, Clozel M, Schreiber J, Kubena P, Lunjani N, Mirer D, Rückert B, Satitsuksanoa P, Tan G, Groenen PMA, Bersuch E, Akdis M, Strasser DS, Renner ED, Akdis CA. Boonpiyathad T, et al. Among authors: farine h. Allergy. 2020 Jan;75(1):84-94. doi: 10.1111/all.13967. Epub 2019 Nov 3. Allergy. 2020. PMID: 31267528

4

ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.

Pouzol L, Baumlin N, Sassi A, Tunis M, Marrie J, Vezzali E, Farine H, Mentzel U, Martinic MM. Pouzol L, et al. Among authors: farine h. FASEB J. 2021 Mar;35(3):e21431. doi: 10.1096/fj.202002465R. FASEB J. 2021. PMID: 33595155

5

Pharmacokinetics, pharmacodynamics, tolerability and prediction of clinically effective dose of ACT-774312: A novel CRTH2 antagonist.

Géhin M, Lott D, Farine H, Issac M, Strasser D, Sidharta P, Dingemanse J. Géhin M, et al. Among authors: farine h. Basic Clin Pharmacol Toxicol. 2019 Jun;124(6):711-721. doi: 10.1111/bcpt.13197. Epub 2019 Feb 11. Basic Clin Pharmacol Toxicol. 2019. PMID: 30589994 Free article. Clinical Trial.

6

A novel CRTH2 antagonist: Single- and multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT-453859 in healthy subjects.

Géhin M, Strasser DS, Zisowsky J, Farine H, Groenen PM, Dingemanse J, Sidharta PN. Géhin M, et al. Among authors: farine h. J Clin Pharmacol. 2015 Jul;55(7):787-97. doi: 10.1002/jcph.478. Epub 2015 Mar 30. J Clin Pharmacol. 2015. PMID: 25655470 Clinical Trial.

7

Identification of cathepsin L as a potential sex-specific biomarker for renal damage.

Bauer Y, Hess P, Qiu C, Klenk A, Renault B, Wanner D, Studer R, Killer N, Stalder AK, Stritt M, Strasser DS, Farine H, Kauser K, Clozel M, Fischli W, Nayler O. Bauer Y, et al. Among authors: farine h. Hypertension. 2011 Apr;57(4):795-801. doi: 10.1161/HYPERTENSIONAHA.110.157206. Epub 2011 Feb 28. Hypertension. 2011. PMID: 21357272

8

Immunoaffinity Targeted Mass Spectrometry Analysis of Human Plasma Samples Reveals an Imbalance of Active and Inactive CXCL10 in Primary Sjögren's Syndrome Disease Patients.

Schmidt A, Farine H, Keller MP, Sebastian A, Kozera L, Welford RWD, Strasser DS. Schmidt A, et al. Among authors: farine h. J Proteome Res. 2020 Oct 2;19(10):4196-4209. doi: 10.1021/acs.jproteome.0c00494. Epub 2020 Sep 15. J Proteome Res. 2020. PMID: 32870689

9

Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics.

Agache I, Strasser DS, Klenk A, Agache C, Farine H, Ciobanu C, Groenen PM, Akdis CA. Agache I, et al. Among authors: farine h. Allergy. 2016 Aug;71(8):1192-202. doi: 10.1111/all.12906. Epub 2016 Apr 29. Allergy. 2016. PMID: 27060452

10

Multiple-ascending doses of ACT-1014-6470, an oral complement factor 5a receptor 1 (C5a₁ receptor) antagonist: Tolerability, pharmacokinetics and target engagement.

Anliker-Ort M, Dingemanse J, Farine H, Groenen P, Kornberger R, van den Anker J, Kaufmann P. Anliker-Ort M, et al. Among authors: farine h. Br J Clin Pharmacol. 2023 Jan;89(1):380-389. doi: 10.1111/bcp.15508. Epub 2022 Sep 7. Br J Clin Pharmacol. 2023. PMID: 36000981 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results